September 11, 2017
Onxeo Announces Top-Line Results from ReLive Phase III Study of Livatag® in Advanced Hepatocellular Carcinoma
Media
September 08, 2017
EBV treatment may be alternative to lung volume reduction surgery for patients with severe emphysema
September 05, 2017
Strongbridge Biopharma plc to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
September 04, 2017
Nordic Nanovector to Present at Pareto Securities’ 8th Annual HealthCare Conference
August 25, 2017
Oncopeptides AB Interim Report April – June 2017
August 24, 2017
Targovax ASA: Second quarter and first half 2017 results
August 24, 2017
Wilson Therapeutics AB (publ) Interim Report January 1 – June 30, 2017
August 23, 2017
Nordic Nanovector ASA – Results for Second Quarter and First Half Year 2017
August 23, 2017
Targovax ASA: Abstracts accepted for poster presentation at the ESMO 2017 Congress
August 21, 2017
Altimmune Submits Investigational New Drug Application for NasoVAX in Preparation for Phase 2 Trial
